+321 123 4567
info@test.com
My Account
  1. Home
  2. /
  3. Availability
  4. /
  5. Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India

Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India

Description

We estimated the impact and cost-effectiveness of six scenarios of routine adolescent M72/AS01E-like vaccination in South Africa and India.
WHO goals and milestones
Availability, Economic impact/cost-effectivenss

Project details

Country
India, South Africa
Timeline
Target group
adolescents
Vaccine
M72/AS01e
Type of protection of vaccine
Prevention of disease
Type of research
Modelling
Partners involved
BMGF; LSHTM; Sanofi Pasteur
Type of project

Resources

Contact

Joeri Buis

KNCV Team

Contact me for more information about this research

Click to copy link of this header Menu

Add A Knowledge Base Question !

You will receive an email when your question will be answered.

+ = Verify Human or Spambot ?